Prapa I, Yanni A, Kompoura V, Mitropoulou G, Panas P, Kostomitsopoulos N
Nutrients. 2024; 16(23).
PMID: 39683613
PMC: 11644729.
DOI: 10.3390/nu16234221.
Ferrer M, Buey B, Grasa L, Mesonero J, Latorre E
Cell Stress Chaperones. 2024; 29(6):769-776.
PMID: 39547594
PMC: 11650142.
DOI: 10.1016/j.cstres.2024.11.002.
Ostergaard S, Cetin Z, Rasmussen H, Laerke H, Holst M, Lauridsen C
Front Nutr. 2024; 11:1502967.
PMID: 39545044
PMC: 11560762.
DOI: 10.3389/fnut.2024.1502967.
Prapa I, Kompoura V, Pavlatou C, Nelios G, Mitropoulou G, Kostomitsopoulos N
Microorganisms. 2024; 12(10).
PMID: 39458313
PMC: 11509866.
DOI: 10.3390/microorganisms12102004.
Damianos J, Abdelnaem N, Camilleri M
Clin Gastroenterol Hepatol. 2024; 23(2):205-215.
PMID: 39426645
PMC: 11761393.
DOI: 10.1016/j.cgh.2024.09.007.
Fatty acids and epigenetics in health and diseases.
Chung M, Kim B
Food Sci Biotechnol. 2024; 33(14):3153-3166.
PMID: 39328231
PMC: 11422405.
DOI: 10.1007/s10068-024-01664-3.
Urine and Serum Metabolomic Profiles Differ by Disease Activity in Pregnant Women With Inflammatory Bowel Diseases.
Wu R, Tandon P, Oh J, Ambrosio L, Hotte N, Shah-Gandhi B
Gastro Hep Adv. 2024; 1(6):993-1005.
PMID: 39131249
PMC: 11308627.
DOI: 10.1016/j.gastha.2022.07.008.
The Severity of DSS-Induced Colitis Is Independent of the SCFA-FFAR2/3-GLP-1 Pathway Despite SCFAs Inducing GLP-1 Secretion via FFAR2/3.
Hunt J, Christiansen C, Yassin M, Hartmann B, Offermanns S, Dragsted L
Metabolites. 2024; 14(7).
PMID: 39057718
PMC: 11278623.
DOI: 10.3390/metabo14070395.
Quantifying fecal and plasma short-chain fatty acids in healthy Thai individuals.
Manokasemsan W, Jariyasopit N, Poungsombat P, Kaewnarin K, Wanichthanarak K, Kurilung A
Comput Struct Biotechnol J. 2024; 23:2163-2172.
PMID: 38827233
PMC: 11141283.
DOI: 10.1016/j.csbj.2024.05.007.
Comparative analysis of short-chain fatty acid levels in non-alcoholic steatohepatitis rat model: Impact of high-fat high-fructose (HFHF), high fat, and Western diets.
Mustika S, Handayani D, Rudijanto A, Santosaningsih D, Mariyatun M, Gatya M
Narra J. 2024; 4(1):e670.
PMID: 38798866
PMC: 11125312.
DOI: 10.52225/narra.v4i1.670.
Perfluorooctanesulfonic acid exposure leads to downregulation of 3-hydroxy-3-methylglutaryl-CoA synthase 2 expression and upregulation of markers associated with intestinal carcinogenesis in mouse intestinal tissues.
Tessmann J, Deng P, Durham J, Li C, Banerjee M, Wang Q
Chemosphere. 2024; 359:142332.
PMID: 38754493
PMC: 11157449.
DOI: 10.1016/j.chemosphere.2024.142332.
Effect of Stool Sampling on a Routine Clinical Method for the Quantification of Six Short Chain Fatty Acids in Stool Using Gas Chromatography-Mass Spectrometry.
Mahdi T, Desmons A, Krasniqi P, Lacorte J, Kapel N, Lamaziere A
Microorganisms. 2024; 12(4).
PMID: 38674773
PMC: 11052040.
DOI: 10.3390/microorganisms12040828.
The connection between fatty acids and inflammation in celiac disease; a deep exploring.
Bakhtiari S, Asri N, Jahdkaran M, Rezaei-Tavirani M, Jahani-Sherafat S, Rostami-Nejad M
Tissue Barriers. 2024; 13(1):2342619.
PMID: 38618691
PMC: 11875481.
DOI: 10.1080/21688370.2024.2342619.
From gut to brain: understanding the role of microbiota in inflammatory bowel disease.
Wang S, Zhou S, Han Z, Yu B, Xu Y, Lin Y
Front Immunol. 2024; 15:1384270.
PMID: 38576620
PMC: 10991805.
DOI: 10.3389/fimmu.2024.1384270.
Molecular Targets of Valeric Acid: A Bioactive Natural Product for Endocrine, Metabolic, and Immunological Disorders.
Kumari B, Kumari U, Singh D, Husain G, Patel D, Shakya A
Endocr Metab Immune Disord Drug Targets. 2024; 24(13):1506-1517.
PMID: 38375842
DOI: 10.2174/0118715303262653231120043819.
Quantifying Gut Microbial Short-Chain Fatty Acids and Their Isotopomers in Mechanistic Studies Using a Rapid, Readily Expandable LC-MS Platform.
Weng C, Suarez C, Cheang S, Couture G, Goodson M, Barboza M
Anal Chem. 2024; 96(6):2415-2424.
PMID: 38288711
PMC: 10867797.
DOI: 10.1021/acs.analchem.3c04352.
Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease.
Yao Y, Liu Y, Xu Q, Mao L
Molecules. 2024; 29(2).
PMID: 38257292
PMC: 10818876.
DOI: 10.3390/molecules29020379.
Exploring the intestinal ecosystem: from gut microbiota to associations with subtypes of inflammatory bowel disease.
Li F, Yu C, Zhao Q, Wang Z, Wang Z, Chang Y
Front Cell Infect Microbiol. 2024; 13:1304858.
PMID: 38239508
PMC: 10794348.
DOI: 10.3389/fcimb.2023.1304858.
The Impact of Dietary Interventions on the Microbiota in Inflammatory Bowel Disease: A Systematic Review.
Nieva C, Pryor J, Williams G, Hoedt E, Burns G, Eslick G
J Crohns Colitis. 2023; 18(6):920-942.
PMID: 38102104
PMC: 11147801.
DOI: 10.1093/ecco-jcc/jjad204.
Gut microbiota in pathophysiology, diagnosis, and therapeutics of inflammatory bowel disease.
Pandey H, Jain D, Tang D, Wong S, Lal D
Intest Res. 2023; 22(1):15-43.
PMID: 37935653
PMC: 10850697.
DOI: 10.5217/ir.2023.00080.